The litigation covers investors who held Endava securities between September 4, 2025, and September 21, 2026. Hagens Berman alleges that the company misled shareholders by asserting its financial statements were accurate, while simultaneously failing to disclose that specific customer and supplier agreements required deeper scrutiny. These omissions ultimately forced a delay in the release of Endava’s fourth-quarter and full-year 2026 financial results.
Market confidence evaporated on September 21, 2026, when the firm announced Thurston’s suspension and the launch of an internal investigation prompted by outside auditors. Reed Kathrein, the partner leading the case, stated the investigation is examining whether the company must restate historical financial data and if these adjustments undermine claims that Endava’s AI-focused pivot was gaining traction. Investors seeking to participate as lead plaintiffs have until November 30, 2026, to submit their claims.



Comments (0)
No comments yet. Be the first!